Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1Sarcoma 1Other solid neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1

Interventions

Specimen Handling 22fludarabine 20Cyclophosphamide 19Biopsy 19fludarabine phosphate 15Cytarabine 13Whole-Body Irradiation 11Busulfan 11Tacrolimus 10Mycophenolic Acid 10Melphalan 10venetoclax 9X-Rays 9decitabine and cedazuridine drug combination 8Magnetic Resonance Spectroscopy 8Injections 8asciminib 7Granulocyte Colony-Stimulating Factor 7Cyclosporine 7ruxolitinib 6Thiotepa 6Sirolimus 6Nuclear Medicine Department, Hospital 6Azacitidine 6Stem Cell Transplantation 5Phantoms, Imaging 5Peripheral Blood Stem Cell Transplantation 5Idarubicin 5Filgrastim 5CPX-351 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blood Component Removal × Myeloid × 30 days × Clear all
NCT06928662 2026-05-15

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
36 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡